A natural variation-based screen in mouse cells reveals USF2 as a regulator of the DNA damage response and cellular

Taekyu Kang1,2, Emily C Moore3, Emily E K Kopania3

  • 1Buck Institute for Research on Aging, Novato, CA 94945, USA.

G3 (Bethesda, Md.)
|April 25, 2023
PubMed

Insights

Upstream stimulatory factor 2 (USF2) helps repair DNA damage and prevents excessive cellular senescence. This discovery offers new insights into senescence regulation and identifies USF2 as a key factor.

Area of Science:

  • Cellular and Molecular Biology
  • Genetics and Genomics
  • Aging Research

Background:

  • Cellular senescence is a stress-induced cell cycle arrest with implications for aging and disease.
  • Known regulators include p16INK4a, p21, NF-κB, p53, and C/EBPβ.
  • Identifying novel senescence regulators is crucial for understanding cellular aging mechanisms.

Purpose of the Study:

  • To discover novel molecular regulators of cellular senescence using evolutionary divergence between mouse species.
  • To investigate the role of upstream stimulatory factor 2 (USF2) in senescence.
  • To elucidate the function of USF2 in DNA damage response and senescence.

Main Methods:

  • Developed a screening approach leveraging genetic variation between Mus spretus and Mus musculus.
  • Utilized allele-specific expression profiling to identify senescence-dependent cis-regulatory variation.
  • Performed molecular validation of candidate regulators, focusing on USF2, through gene knockout and cellular assays.

Main Results:

  • Mus spretus cells showed reduced cytokine production and lysosomal activity during senescence compared to Mus musculus.
  • USF2-deficient cells exhibited impaired DNA damage repair and response.
  • Loss of USF2 led to an exaggerated senescence program, including accelerated cell cycle arrest and increased cytokine expression.

Conclusions:

  • USF2 functions as a pro-repair, anti-senescence regulator.
  • This study provides new insights into the commitment mechanisms of cellular senescence.
  • Natural variation-based screening is a validated approach for discovering regulator genes.